Unicharm Co. (OTCMKTS:UNICY – Get Free Report) saw a large decline in short interest in the month of July. As of July 15th, there was short interest totalling 77,900 shares, a decline of 66.1% from the June 30th total of 229,900 shares. Based on an average daily trading volume, of 246,300 shares, the days-to-cover ratio is currently 0.3 days.
Unicharm Trading Down 1.5 %
OTCMKTS UNICY traded down $0.10 during trading hours on Thursday, hitting $6.47. The company’s stock had a trading volume of 147,085 shares, compared to its average volume of 187,222. Unicharm has a twelve month low of $5.55 and a twelve month high of $8.49. The firm has a market capitalization of $19.09 billion, a P/E ratio of 32.35 and a beta of 0.20. The company has a quick ratio of 1.98, a current ratio of 2.37 and a debt-to-equity ratio of 0.02. The stock has a fifty day moving average of $6.54 and a 200 day moving average of $6.55.
Unicharm (OTCMKTS:UNICY – Get Free Report) last issued its earnings results on Tuesday, May 7th. The company reported $0.04 EPS for the quarter. Unicharm had a net margin of 9.12% and a return on equity of 11.07%. The company had revenue of $1.59 billion during the quarter. Equities research analysts forecast that Unicharm will post 0.2 earnings per share for the current fiscal year.
Unicharm Company Profile
Unicharm Corporation engages in the manufacturing and sale of wellness, feminine, baby and children, kirei, and pet care products in Japan and internationally. The company's baby and child care products, including disposable diapers and wipes under the Moony, MamyPoko, Oyasumiman, and Torepanman brands; feminine care products comprise napkins, tampons, panty liners, sanitary short, panty liners, and other feminine care products under the Sofy, Center-In, and Unicharm brand names; and wellness care products include napkin-type incontinence pads, pants-type diapers, tape-type diapers, pants-type specialized urine pads, and tape-type specialized urine pads under the Lifree and Charmnap brand.
See Also
- Five stocks we like better than Unicharm
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Viking Therapeutics: Pharma Stock Soars on Positive Earnings
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Top 3 Small Cap Stocks Emerging as Rotation Winners
- What to Know About Investing in Penny Stocks
- Bargain Alert: 3 Stocks Worth Watching While The Market Cools
Receive News & Ratings for Unicharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Unicharm and related companies with MarketBeat.com's FREE daily email newsletter.